We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSIQ icon
401
Canadian Solar
CSIQ
$1.05B
$322K 0.05%
10,430
-803
-7% -$27K
GGG icon
402
Graco
GGG
$13.4B
$322K 0.05%
+4,785
New +$319K
KLIC icon
403
Kulicke & Soffa
KLIC
$4.91B
$321K 0.05%
7,258
-2,195
-23% -$96.5K
EXR icon
404
Extra Space Storage
EXR
$31.7B
$318K 0.05%
2,163
-881
-29% -$141K
AVB icon
405
AvalonBay Communities
AVB
$27.1B
$317K 0.05%
+1,964
New +$334K
PHM icon
406
Pultegroup
PHM
$25.3B
$316K 0.05%
+6,938
New +$292K
RVTY icon
407
Revvity
RVTY
$12.8B
$314K 0.05%
+2,238
New +$301K
SFNC icon
408
Simmons First National
SFNC
$3.47B
$311K 0.05%
14,390
-2,225
-13% -$50.5K
ASB icon
409
Associated Banc-Corp
ASB
$5.95B
$309K 0.05%
13,396
-2,408
-15% -$55.6K
BJ icon
410
BJs Wholesale Club
BJ
$12.3B
$306K 0.05%
4,625
-4,006
-46% -$290K
WCN
411
Waste Connections
WCN
$41.5B
$305K 0.05%
+2,300
New +$313K
OGE icon
412
OGE Energy
OGE
$9.71B
$305K 0.05%
+7,705
New +$292K
BCC icon
413
Boise Cascade
BCC
$2.98B
$304K 0.05%
+4,432
New +$302K
DEN
414
DELISTED
Denbury Inc.
DEN
$304K 0.05%
+3,492
New +$317K
ATR icon
415
AptarGroup
ATR
$8.69B
$300K 0.05%
2,724
+192
+8% +$19.7K
ROKU icon
416
Roku
ROKU
$21.8B
$295K 0.05%
7,250
+2,759
+61% +$144K
BCRX icon
417
BioCryst Pharmaceuticals
BCRX
$2.31B
$294K 0.05%
25,637
+5,114
+25% +$63.8K
INSM icon
418
Insmed
INSM
$21.5B
$291K 0.05%
14,552
-8,526
-37% -$165K
TXT icon
419
Textron
TXT
$15.2B
$286K 0.05%
+4,043
New +$274K
GWRE icon
420
Guidewire Software
GWRE
$13.3B
$285K 0.05%
+4,553
New +$270K
INMD icon
421
InMode
INMD
$874M
$282K 0.05%
+7,887
New +$274K
INGR icon
422
Ingredion
INGR
$6.51B
$279K 0.05%
2,852
-1,157
-29% -$107K
MZTI
423
The Marzetti Company
MZTI
$3.05B
$277K 0.05%
+1,405
New +$267K
ACAD icon
424
Acadia Pharmaceuticals
ACAD
$4.93B
$275K 0.05%
17,292
-12,826
-43% -$200K
APO icon
425
Apollo Global Management
APO
$74.8B
$274K 0.05%
4,301
-9,884
-70% -$587K
15 16
17
18 19

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.